SE9904660D0 - Novel assays - Google Patents

Novel assays

Info

Publication number
SE9904660D0
SE9904660D0 SE9904660A SE9904660A SE9904660D0 SE 9904660 D0 SE9904660 D0 SE 9904660D0 SE 9904660 A SE9904660 A SE 9904660A SE 9904660 A SE9904660 A SE 9904660A SE 9904660 D0 SE9904660 D0 SE 9904660D0
Authority
SE
Sweden
Prior art keywords
assays
novel assays
sphingosine
novel
agonists
Prior art date
Application number
SE9904660A
Other languages
English (en)
Swedish (sv)
Inventor
Sultan Ahmad
Paola Lembo
Philippe Walker
Original Assignee
Astra Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Inc filed Critical Astra Pharma Inc
Priority to SE9904660A priority Critical patent/SE9904660D0/xx
Publication of SE9904660D0 publication Critical patent/SE9904660D0/xx
Priority to EP00987917A priority patent/EP1242820A2/fr
Priority to CA002395175A priority patent/CA2395175A1/fr
Priority to PCT/SE2000/002563 priority patent/WO2001044439A2/fr
Priority to US10/168,262 priority patent/US20030129664A1/en
Priority to AU24185/01A priority patent/AU779344B2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/08—Sphingolipids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9904660A 1999-12-17 1999-12-17 Novel assays SE9904660D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE9904660A SE9904660D0 (sv) 1999-12-17 1999-12-17 Novel assays
EP00987917A EP1242820A2 (fr) 1999-12-17 2000-12-15 Detection des ligands du recepteur (hgir,rp-23) induite par des glucocorticoides
CA002395175A CA2395175A1 (fr) 1999-12-17 2000-12-15 Criblage du ligand (hgir,rp-23) par le recepteur induit de glucorticoide
PCT/SE2000/002563 WO2001044439A2 (fr) 1999-12-17 2000-12-15 Nouvelles analyses biologiques
US10/168,262 US20030129664A1 (en) 1999-12-17 2000-12-15 Novel Assays
AU24185/01A AU779344B2 (en) 1999-12-17 2000-12-15 Novel assays

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904660A SE9904660D0 (sv) 1999-12-17 1999-12-17 Novel assays

Publications (1)

Publication Number Publication Date
SE9904660D0 true SE9904660D0 (sv) 1999-12-17

Family

ID=20418196

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9904660A SE9904660D0 (sv) 1999-12-17 1999-12-17 Novel assays

Country Status (6)

Country Link
US (1) US20030129664A1 (fr)
EP (1) EP1242820A2 (fr)
AU (1) AU779344B2 (fr)
CA (1) CA2395175A1 (fr)
SE (1) SE9904660D0 (fr)
WO (1) WO2001044439A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009023A1 (en) * 2001-07-03 2005-01-13 Neil Richtand Glucocorticoid-induced receptor and methods of use
WO2003008445A1 (fr) * 2001-07-19 2003-01-30 Takeda Chemical Industries, Ltd. Nouvelle proteine receptrice couplee a la proteine g, et adn codant pour elle
AU2003205627A1 (en) * 2002-02-01 2003-09-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with gpr72
WO2007035551A1 (fr) * 2005-09-19 2007-03-29 Eisai R & D Management Co., Ltd. Methodes d'identification des agonistes et des antagonistes gpr83 capables de moduler la fonction regulatrice des lymphocytes t
EP1867994B1 (fr) * 2006-06-13 2012-09-26 Euroscreen S.A. Ligand pour protéine G couplé au récepteur GPR72 et utilisations correspondantes
CA2589393C (fr) 2006-06-13 2016-04-12 Euroscreen S.A. Ligand pour recepteur gpr72 lie a la proteine-g et utilisations connexes
US8557533B2 (en) 2007-02-01 2013-10-15 Helmut Jonuleit Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4855393A (en) * 1992-09-10 1994-03-29 New York University Polypeptides of g-coupled receptor proteins, and compositions and methods thereof
CN1165147A (zh) * 1996-02-07 1997-11-19 武田药品工业株式会社 鸟嘌呤核苷酸结合蛋白偶联受体蛋白质，其生产和应用
CA2231754A1 (fr) * 1997-05-07 1998-11-07 Smithkline Beecham Corporation Nouveau recepteur humain, hcept09, couple aux proteines g

Also Published As

Publication number Publication date
EP1242820A2 (fr) 2002-09-25
AU779344B2 (en) 2005-01-20
US20030129664A1 (en) 2003-07-10
AU2418501A (en) 2001-06-25
WO2001044439A2 (fr) 2001-06-21
WO2001044439A3 (fr) 2001-12-13
CA2395175A1 (fr) 2001-06-21

Similar Documents

Publication Publication Date Title
TR200100267T2 (tr) İkameli anilid bileşimleri ve yöntemler.
EA200101177A1 (ru) Производные индола в качестве антагонистов прогестерона
DE60214990D1 (de) Benzolsulfonsäureester-indol-5-yl als 5-ht6 rezeptor-antagonisten
HU0400405D0 (en) Novel compounds
EA200301073A1 (ru) N-(2-арилэтил)бензиламины в качестве антагонистов 5-ht-рецептора
PT1206473E (pt) Pirrolocarbazoles e isoindolonas fundidos isomericos
CY1115124T1 (el) Υποκατεστημενες 3-κυανοκινολινες ως αναστολεις κινασων πρωτεϊνης τυροσινης
DK1337518T3 (da) Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren
NO20001940D0 (no) Bicykliske kinase-inhibitorer
YU80902A (sh) Novi indolin-2-on derivati, njihovo dobijanje i farmaceuski oblici koji ih sadrže
EA200201119A1 (ru) Лиганды меланокортиновых рецепторов
ATE274348T1 (de) Überbrückte indenopyrrolocarbazole
TR199902883T2 (xx) NK-2 ve NK-3 resept�r antagonistleri olarak kuinolin-4-karboksamid t�revleri.
EA200001039A1 (ru) Кальцилитические соединения
SE0103710D0 (sv) Compounds
EA200400454A1 (ru) Мускариновые агонисты
MY133390A (en) Azabicyclic 5ht1 receptor ligands
SE9904660D0 (sv) Novel assays
BG105847A (en) Calcilytic compounds
DE60041001D1 (de) Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien
EE200300092A (et) EDb-fibronektiinidomeeni retseptor
DK1206452T3 (da) Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser
ATE441642T1 (de) Hydantoin derivate mit affinität für somatostatin rezeptoren
ATE408144T1 (de) Assays
EA200100299A1 (ru) Уреидопиперидиновые производные как селективные антагонисты nk3 - рецепторов человека